The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $597,000 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The Pennsylvania State University (Penn State) to conduct research on the effects of adolescent binge drinking on behavioral profiles, somatostatin neuron function, and functional connectivity in the prefrontal cortex. The research aims to characterize sex-specific, long-term impacts of adolescent alcohol exposure on cortical signaling and brain...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, will support research to investigate the role of sex chromosomes in alcohol drinking behaviors. The total award amount is $321,102 and the project will run from August 1, 2024 to July 31, 2029. The key objectives of the research are to: 1) demonstrate that alcohol consumption is reduced in mice with two X chromosomes compared to...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $249,000.00 to the University of North Carolina at Wilmington to investigate how adolescent binge drinking impacts the integration of newborn neurons into mature hippocampal circuitry. The research aims to elucidate the cellular and physiological mechanisms by which adolescent alcohol exposure disrupts the maturation and circuit integration...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will provide $221,375 to Oregon Health & Science University (OHSU) to investigate the role of the anterior olfactory system in regulating alcohol consumption. The key objectives are to examine whether chemogenetic activation of oxytocin receptor (OXTR)-containing neurons in the anterior olfactory nucleus (AON) and vasopressin...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,351,034 to the University of Alabama at Birmingham (UAB) to research the mechanisms by which somatostatin-expressing interneurons (SST-INs) in the prelimbic region of the prefrontal cortex regulate natural and drug reward seeking behaviors. The 5-year project aims to: 1) reveal the in vivo dynamics, behavioral contributions, and...
This Project Grant award of $509,683.37 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a translational research program focused on understanding individual differences in risk for alcohol use disorder (AUD). The program aims to translate a preclinical model of individual differences in the attribution of incentive salience (IS) to reward-predictive cues into a human laboratory model examining individual...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, provides $499,442 in funding to The Regents of the University of California, San Francisco (UCSF) from August 20, 2024 through July 31, 2027. The award supports research to investigate the role of brain-derived neurotrophic factor (BDNF) signaling in the ventral hippocampus and its contribution to the acute anxiolytic and social...
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate the neural mechanisms driving adaptive stress coping behaviors and subsequent alcohol use. The $498,121.57 award, effective August 15, 2024 through July 31, 2027, will utilize an animal model to explore how dysfunction in the corticolimbic circuitry, specifically the prelimbic cortex and basolateral...
This federal Project Grant award for $180,360 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research on the role of the neuropeptide somatostatin (SST) in the extended amygdala in reducing post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) comorbidity. The research, conducted by the Scripps Research Institute in La Jolla, CA, will utilize a multidisciplinary approach including in situ...
This Project Grant award of $781,032 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to understand the interplay between norepinephrine and dopamine circuits in the brain and their role in sex differences related to reward and aversion, including substance use disorders. Specifically, the research aims to map the anatomical and neurochemical distribution of norepinephrine projections from...